This patent covers the composition of matter for several inhibitors of proteasomal activity including inhibitors of the chymotrypsin-like activity, and NF-KB inhibitors that stimulate hair growth. The invention has demonstrated efficacy in several animal models and is currently being developed by the San Francisco company Neosil.
One wonders whether inhibition of inflammation-associated transcription factors may also be used to stimulate other types of stem cells.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.